Overview
Background
Matthew J. Roberts, BSc, MBBS, PhD, FRACS (Urol)
- Consultant Urologist, Royal Brisbane and Women’s (RBWH), Surgical Treatment and Rehabilitation Service (STARS), Queensland Health
- Clinician Research Fellow, Metro North Hospital and Health Service
- Group Leader & Associate Professor, The University of Queensland Centre for Clinical Research
Matthew is a medical graduate of The University of Queensland and completed Urology specialty training in Queensland and New South Wales. He completed his PhD under the supervision of Professor “Frank” Gardiner investigating new biomarkers for the early detection and characterization of prostate cancer.
Matthew is a surgeon-scientist, working clinically as a urologist and robotic surgeon at RBWH & STARS with academic appointment as Clinician Research Fellow at Metro North Health (Qld) and Associate Professor at UQCCR. His clinical and research interests are in Urologic cancers (e.g. prostate cancer), focusing on novel imaging and biomarkers, clinical trials, urological infections and innovation in urology. He has authored over 140 peer reviewed manuscripts in international journals and presented research at more than 20 international urology and clinical cancer meetings. He is a member of the EAU Prostate Cancer Guidelines Committee, Prostate Cancer Outcomes Registry (PCOR)-Queensland Steering Committee, Editorial Board of the BJU International, as well as Co-Convenor of the ANZUP 2024 ASM.
Availability
- Dr Matthew Roberts is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Biomedical Science, The University of Queensland
- Bachelor of Medicine, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Research interests
-
Urology
All fields related to urology including urologic oncology, prostate cancer, kidney/renal cancer, bladder cancer and others. Urologic infections Quality-of-life and survivorship research Systematic review and meta-analysis.
Works
Search Professor Matthew Roberts’s works on UQ eSpace
2024
Journal Article
Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach
Collin, Harry, Roberts, Matthew J., Keogh, Kandice, Siriwardana, Amila and Basto, Marnique (2024). Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach. BJUI Compass, 6 (1) e427, e427. doi: 10.1002/bco2.427
2024
Journal Article
A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware
Mehawed, Georges, Roberts, Matthew J., Bugeja, Jessica, Dowling, Jason, Stewart, Kate, Gunasena, Rivindi, Malczewski, Frances, Rukin, Nicholas J. and Murray, Rebecca (2024). A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware. Journal of Clinical Medicine, 13 (23) 7384, 1-11. doi: 10.3390/jcm13237384
2024
Journal Article
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics
Roberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482
2024
Conference Publication
The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
Teppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610
2024
Conference Publication
The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.
2024
Journal Article
The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers
Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019
2024
Journal Article
The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort
Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Pelecanos, Anita, Gan, Chun Loo, Goh, Jeffrey C., Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2024). The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort. European Urology Focus, 10 (5), 770-778. doi: 10.1016/j.euf.2023.12.004
2024
Journal Article
Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care
Lindsay, Daniel, Schofield, Penelope, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Collins, Louisa G. (2024). Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care. European Urology Oncology, 8 (3), 674-680. doi: 10.1016/j.euo.2024.08.005
2024
Journal Article
Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography primary score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer
Emmett, Louise, Papa, Nathan, Hope, Thomas A., Fendler, Wolfgang, Calais, Jeremie, Burger, Irene, Eiber, Matthias, Barbato, Francesco, Moon, Daniel, Counter, William, John, Nikeith, Xue, Alan, Franklin, Anthony, Thompson, James, Rasiah, Kris, Frydenberg, Mark, Yaxley, John, Buteau, James, Agrawal, Shikha, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Woo, Henry, Hsiao, Edward, Sutherland, Thomas, Perry, Elyse, Stricker, Phillip, Hofman, Michael S. ... Murphy, Declan (2024). Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography primary score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. The Journal of Urology, 212 (2), 299-309. doi: 10.1097/JU.0000000000004010
2024
Journal Article
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intent
Cornford, Philip, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, van Leenders, Geert J.L.H., Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Tilki, Derya (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intent. European Urology, 86 (2), 148-163. doi: 10.1016/j.eururo.2024.03.027
2024
Journal Article
ChatGPT can help guide and empower patients after prostate cancer diagnosis
Collin, Harry, Keogh, Kandice, Basto, Marnique, Loeb, Stacy and Roberts, Matthew J. (2024). ChatGPT can help guide and empower patients after prostate cancer diagnosis. Prostate Cancer and Prostatic Diseases, 28 (2) 87, 513-515. doi: 10.1038/s41391-024-00864-6
2024
Journal Article
Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer
Buteau, James P., Moon, Daniel, Fahey, Michael T., Roberts, Matthew J., Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, De Abreu Lourenco, Richard, Dhillon, Haryana M., Kasivisvanathan, Veeru, Francis, Roslyn J., Stricker, Phillip, Agrawal, Shihka, O'Brien, Jonathan, McVey, Aoife, Sharma, Gaurav, Levy, Sidney, Ayati, Narjess, Nguyen, Andrew, Lee, Su-Faye, Pattison, David A., Sivaratnam, Dinesh, Frydenberg, Mark, Du, Yang, Titus, Jehan, Lee, Sze-Ting, Ischia, Joseph, Jack, Greg ... Emmett, Louise (2024). Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. European Urology Oncology, 7 (3), 544-552. doi: 10.1016/j.euo.2023.11.008
2024
Journal Article
Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more
Mehawed, Georges, Murray, Rebecca, Wang, Kevin, Roberts, Matthew J. and Rukin, Nicholas J. (2024). Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more. BJU International, 134 (S2), 14-16. doi: 10.1111/bju.16374
2024
Journal Article
What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies
Wynn, Jessica, Homewood, David, Tse, Vincent, Fong, Eva, Roberts, Matthew J., Chung, Eric and Dowling, Caroline (2024). What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies. Australian Journal of General Practice, 53 (5), 265-273. doi: 10.31128/AJGP-10-23-7004
2024
Journal Article
Prostate tumour visualisation with PET: is image fusion with MRI the answer?
Mehawed, Georges, Murray, Rebecca, Rukin, Nicholas J. and Roberts, Matthew J. (2024). Prostate tumour visualisation with PET: is image fusion with MRI the answer?. BJU International, 133 (Supplement 4), 4-6. doi: 10.1111/bju.16335
2024
Journal Article
Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study
Roberts, Natasha A., Esler, Rachel, Pearce, Adam, Wyld, David, Smith, Michael, Woollett, Kaylene, Mazariego, Carolyn and Roberts, Matthew J. (2024). Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study. European Urology Open Science, 62, 36-42. doi: 10.1016/j.euros.2024.01.018
2024
Journal Article
Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?
Roberts, Matthew J., Yaxley, John W., Stranne, Johan, van Oort, Inge M. and Tilki, Derya (2024). Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?. Prostate Cancer and Prostatic Diseases, 28 (2) e430466, 1-3. doi: 10.1038/s41391-024-00821-3
2024
Journal Article
Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy
Dey, Shuvashis, Kinoshita, Masaki, Puttick, Simon, Rose, Stephen, Trau, Matt, Roberts, Matthew J. and Koo, Kevin M. (2024). Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy. Advanced Sensor Research, 3 (7) 2300193. doi: 10.1002/adsr.202300193
2024
Conference Publication
Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT
Zuur, L.G., de Bie, K., Vis, A.N., Van Der Poel, H.G., Donswijk, M.L., Oprea-Lager, D.E., Roberts, M. and Van Leeuwen, P.J. (2024). Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01187-4
2024
Conference Publication
Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer
Emmett, L., Papa, N., Hope, T., Fendler, W., Calais, J., Burger, I., Eiber, M., Barbato, F., Moon, D., Xue, A., Franklin, A., Thompson, J., Rasiah, K., Frydenberg, M., Yaxley, J., Buteau, J., Liu, V., Nguyen, A., Hsiao, E., Stricker, P., Hofman, M., Kasivisvanathan, V., Roberts, M. and Murphy, D. (2024). Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00417-2
Funding
Current funding
Supervision
Availability
- Dr Matthew Roberts is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices
Associate Advisor
Other advisors: Professor Kristofer Thurecht
-
Doctor Philosophy
Multi-Bioanalyte Profiling of Metastatic Castration-Resistant Prostate Cancer in a Phase 2 STATEsMAN Trial
Associate Advisor
Other advisors: Associate Professor Amy McCart Reed
Media
Enquiries
For media enquiries about Dr Matthew Roberts's areas of expertise, story ideas and help finding experts, contact our Media team: